25. Events after the reporting period

On July 5, 2026, 13,250,000 ordinary shares held by Luso Global Mining B.V. were released from voluntary escrow.

On July 9, 2026, the Company publicly filed a registration statement on Form F-1 with the US Securities and Exchange Commission (SEC) for an initial public offering (IPO) in the United States and a listing on the Nasdaq Capital Market. The SEC declared the registration statement effective on September 29, 2026 (US time), and the Company’s American Depositary Shares (ADSs), each representing 10 ordinary shares, began trading on the Nasdaq Capital Market on October 1, 2026.

On October 2, 2026, the Company completed the IPO of 625,000 ADSs and accompanying warrants to purchase 625,000 ADSs, at a combined public offering price of US$5.60 per ADS and warrant, for gross proceeds of US$3,500,000. At closing, the underwriter, Maxim Group LLC, partially exercised its over-allotment option to purchase 92,000 additional warrants for US$920. On October 5, 2026 the Company received US$3,143,118, being gross proceeds of US$3,500,920 less the underwriting discount of US$257,802 and the US$100,000 balance of the underwriter’s expenses of US$125,000 (US$25,000 of which was advanced in November 2025). In connection with the IPO, the Company issued 6,250,000 ordinary shares represented by the ADSs, warrants to purchase 717,000 ADSs (625,000 issued with the ADSs and 92,000 purchased by the underwriter) at US$5.60 per ADS exercisable until October 2, 2031, and a representative’s warrant to Maxim Partners LLC, an affiliate of the underwriter, to purchase 31,250 ADSs at US$7.00 per ADS exercisable until September 30, 2031.

On September 30, 2026, Luso Global Mining B.V. (Luso), a substantial shareholder, a wholly owned subsidiary of Mota-Engil, SGPS, S.A. and a related party of the Group, provided a letter of financial support under which it agreed to provide up to A$1,500,000, if required, for twelve months or until completion of the IPO, whichever occurred first. The support ended on completion of the IPO in October 2026, and no amount was drawn.

On October 12, 2026, the Company issued 98,250 ordinary shares on the exercise of 48,251 options at A$0.25 and 49,999 options at A$0.40, for A$32,062.

On October 14, 2026, the Company entered into a premium funding arrangement with IQumulate Premium Funding Pty Ltd for the US$471,696 premium on its directors’ and officers’ insurance, payable by instalments to April 2027.

On October 16, 2026 (New York time), the underwriter purchased a further 56,834 ADSs, representing 568,340 ordinary shares, at US$5.59 per ADS under its over-allotment option, for gross proceeds of US$317,702 (US$292,286 after the underwriting discount), and the Company issued to Maxim Partners LLC a further representative’s warrant to purchase 2,841 ADSs on the same terms. The Company is seeking shareholder ratification of the issue of the representative’s warrants at its annual general meeting on November 25, 2026. The underwriter may purchase up to 35,166 further ADSs under the over-allotment option until November 14, 2026.

Other than the matters set out above, no matter or circumstance has arisen since June 30, 2026 that has significantly affected, or may significantly affect, the Group’s operations, the results of those operations or the Group’s state of affairs in future financial years.

These consolidated financial statements were authorised for issue by the directors on October 26, 2026.